Private Advisor Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $329K | Sell |
1,687
-1,764
| -51% | -$366K | ﹤0.01% | 2052 |
|
|
2026
Q1 | $775K | Sell |
3,451
-234
| -6% | -$58.3K | ﹤0.01% | 1586 |
|
|
2025
Q4 | $888K | Buy |
3,685
+28
| +0.8% | +$7.16K | ﹤0.01% | 1470 |
|
|
2025
Q3 | $1M | Buy |
3,657
+98
| +3% | +$26.8K | ﹤0.01% | 1370 |
|
|
2025
Q2 | $918K | Buy |
3,559
+315
| +10% | +$75.1K | ﹤0.01% | 1356 |
|
|
2025
Q1 | $726K | Buy |
3,244
+501
| +18% | +$117K | ﹤0.01% | 1416 |
|
|
2024
Q4 | $627K | Sell |
2,743
-103
| -4% | -$24.8K | ﹤0.01% | 1451 |
|
|
2024
Q3 | $695K | Sell |
2,846
-225
| -7% | -$50.3K | ﹤0.01% | 1449 |
|
|
2024
Q2 | $588K | Buy |
3,071
+402
| +15% | +$81.6K | ﹤0.01% | 1482 |
|
|
2024
Q1 | $529K | Buy |
2,669
+46
| +2% | +$8.43K | ﹤0.01% | 1482 |
|
|
2023
Q4 | $451K | Buy |
+2,623
| New | +$403K | ﹤0.01% | 1546 |
|
|
2023
Q3 | – | Sell |
-1,698
| Closed | -$376K | – | 2362 |
|
|
2023
Q2 | $376K | Sell |
1,698
-1
| -0.1% | -$223 | ﹤0.01% | 1504 |
|
|
2023
Q1 | $372K | Sell |
1,699
-1,176
| -41% | -$255K | ﹤0.01% | 1452 |
|
|
2022
Q4 | $296K | Buy |
2,875
+650
| +29% | +$143K | 0.01% | 755 |
|
|
2022
Q3 | $486K | Sell |
2,225
-2,676
| -55% | -$609K | 0.01% | 1248 |
|
|
2022
Q2 | $1.03M | Buy |
4,901
+361
| +8% | +$76.9K | 0.01% | 1058 |
|
|
2022
Q1 | $1.1M | Buy |
4,540
+794
| +21% | +$192K | 0.01% | 1047 |
|
|
2021
Q4 | $976K | Sell |
3,746
-2,055
| -35% | -$533K | 0.01% | 1128 |
|
|
2021
Q3 | $1.53M | Buy |
5,801
+1,533
| +36% | +$419K | 0.01% | 1010 |
|
|
2021
Q2 | $1.05M | Sell |
4,268
-199
| -4% | -$41.8K | 0.01% | 1038 |
|
|
2021
Q1 | $866K | Buy |
4,467
+12
| +0.3% | +$2.41K | 0.01% | 1064 |
|
|
2020
Q4 | $947K | Buy |
4,455
+212
| +5% | +$42.3K | 0.01% | 928 |
|
|
2020
Q3 | $750K | Sell |
4,243
-136
| -3% | -$25.1K | 0.01% | 905 |
|
|
2020
Q2 | $841K | Buy |
4,379
+1,179
| +37% | +$193K | 0.01% | 829 |
|
|
2020
Q1 | $471K | Sell |
3,200
-196
| -6% | -$31.2K | 0.01% | 917 |
|
|
2019
Q4 | $526K | Sell |
3,396
-33
| -1% | -$4.76K | 0.01% | 1024 |
|
|
2019
Q3 | $463K | Sell |
3,429
-1,315
| -28% | -$172K | 0.01% | 1103 |
|
|
2019
Q2 | $579K | Sell |
4,744
-142
| -3% | -$15.7K | 0.01% | 975 |
|
|
2019
Q1 | $508K | Sell |
4,886
-2,125
| -30% | -$219K | 0.01% | 962 |
|
|
2018
Q4 | $798K | Buy |
7,011
+265
| +4% | +$28.4K | 0.02% | 658 |
|
|
2018
Q3 | $778K | Buy |
+6,746
| New | +$739K | 0.02% | 794 |
|
|
2017
Q2 | – | Sell |
-50,266
| Closed | -$73K | – | 1457 |
|
|
2017
Q1 | $73K | Buy |
+50,266
| New | +$3.47M | ﹤0.01% | 1375 |
|
Other funds holding RMD
TIA
WF
VF
AT
AS
TIM
Private Advisor Group's RMD Position: Q2 2026 in Review
Private Advisor Group reduced its ResMed (RMD) stake by 51% in Q2 2026, selling an estimated $366K and leaving 1,687 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #2052.
Private Advisor Group first reported a position in RMD in Q1 2017 and has held it in 32 quarters since. The position peaked at $1.53M in Q3 2021. 319 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Private Advisor Group held 1,687 shares of ResMed worth $329K as of Q2 2026.
- Private Advisor Group sold 1,764 ResMed shares in Q2 2026, an estimated $366K.
- ResMed made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #2052 holding.
- Private Advisor Group first reported a position in ResMed in Q1 2017 and has held it in 32 quarters since.
- Private Advisor Group's ResMed position peaked at $1.53M in Q3 2021.
- 319 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.